18F-FDG PET-CT Simulation for Non-Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 24-30

  Hanna, Gerard G ^a,b   McAleese, Jonathan ^b   Carson, Kathryn J ^c   Stewart, David P ^b   Cosgrove, Vivian P ^b   Eakin, Ruth L ^b   Zatari, Ashraf ^b   Lynch, Tom ^b   Jarritt, Peter H ^c   Young, V A Linda ^b   O'Sullivan, Joe M ^a,b   Hounsell, Alan R ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

computed tomography; lung cancer; non small cell lung cancer; NSCLC; PET CT; Positron emission tomography; radiotherapy planning; target volume definition

Indexed keywords

COMPUTED TOMOGRAPHY; CONCORDANCE INDEX; CT IMAGE; CT SCAN; CT SCANNERS; CT SIMULATION; FDG PET; GROSS TUMOR VOLUME; INDUCTION CHEMOTHERAPY; INTEROBSERVER VARIABILITY; LUNG CANCER; MANN-WHITNEY U TEST; MEAN PERCENTAGE; NON SMALL CELL LUNG CANCER; PLANNING CT; RADICAL RADIOTHERAPY; RADIOTHERAPY PLANNING; SIGNED RANK; TARGET VOLUMES; VIRTUAL PLANNING;

BIOLOGICAL ORGANS; CHEMOTHERAPY; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RADIOTHERAPY; TARGETS;

COMPUTERIZED TOMOGRAPHY;

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; NAVELBINE;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIMULATION; TREATMENT PLANNING; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77950592144     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.045     Document Type: Article

References (19)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality (2007), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute, Atlanta
2. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small-cell lung cancer: Mediastinal staging in the 1990s-Meta-analytic comparison of PET and CT. Radiology 213 (1999) 530-536
3. Freudenberg L.S., Rosenbaum S.J., Beyer T., et al. PET versus PET/CT dual-modality imaging in evaluation of lung cancer. Radiol Clin North Am 45 (2007) 639-644
4. 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small-cell lung cancer. Radiother Oncol 55 (2000) 317-324
5. 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
6. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decreased interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
7. 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys 61 (2005) 649-655
8. 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 709-719
9. van Baardwijk A., Bosmans G., Boersma L., et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumour and involved nodal volumes. Int J Radiat Oncol Biol Phys 68 (2007) 771-778
10. Faria S.L., Menard S., Devic S., et al. Impact of FDG PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathological findings. Int J Radiat Oncol Biol Phys 70 (2008) 1035-1038
11. Caldwell C.B., Mah K., Skinner M., et al. Danjoux CE. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys 55 (2003) 1381-1393
12. Fitton I., Steenbakkers R.J.H.M., Gilhuijs K., et al. Impact of anatomical location of value of CT-PET co-registration for delineation of lung tumors. Int J Radiat Oncol Biol Phys 70 (2008) 1403-1407
13. Giraud P., Elles S., Helfre S., et al. Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 62 (2002) 27-36
14. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
15. Jarritt P., Hounsell A., Carson K.J., et al. Use of combined PET/CT images for radiotherapy planning: Initial experiences in lung cancer. Br J Radiol 28 Suppl (2005) 33-40
16. Bland J.M., and Altman D.G. Agreement between methods of measurement with multiple observations per individual. J Biopharmaceutic Stat 17 (2007) 571-582
17. Beyer T., Antoch G., Blodgett T., et al. Dual modality PET-CT imaging: The effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med 30 (2003) 588-596
18. Hoesktra C.J., Stroobants S.G., Smit E.F., et al. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol 23 (2005) 8362-8370
19. Gagel B., Piroth M., Pinkawa M., et al. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: First results of a phase I/II study. BMC Cancer 7 (2007) 112